年龄相关性黄斑变性

Department of Ophthalmology, University of Birmingham, UK.

Postgrad Med J. 1998 Apr;74(870):203-7. doi: 10.1136/pgmj.74.870.203.

Macular degeneration is now responsible for approximately 95% of blindness and partial sighted registrations in the UK. This review has been written specifically to make the general medical community of the UK aware of the prevalence and clinical manifestations of aged-related macular degeneration. The review encompasses the risk factors, the disabilities and problems experienced by suffers of the condition and current therapeutic options. Age related macular degeneration increases in prevalence in our community from 0% among people under 55 years old to 18.5% among those 85 years or older. There is a marked female preponderance. The exudative form of the disorder is commoner. Treatment remains supportive for most patients with macular degeneration although a minority will benefit from macular laser photocoagulation.

在英国，黄斑变性目前约占失明和视力部分受损登记病例的95%。撰写本综述的目的是让英国的普通医学界了解年龄相关性黄斑变性的患病率和临床表现。该综述涵盖了风险因素、该病患者所经历的残疾和问题以及当前的治疗选择。在我们的社区中，年龄相关性黄斑变性的患病率从55岁以下人群中的0%上升到85岁及以上人群中的18.5%。女性明显占多数。该疾病的渗出型更为常见。尽管少数黄斑变性患者将从黄斑激光光凝治疗中获益，但对大多数患者而言，治疗仍以支持性为主。